Position in GLSI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$900,750
New position
Shares Held
37,500
first reported quarter
Ownership
0.255%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#11
of 63 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 60.13333333333334.ToString("F0")%
Shared 0.ToString("F0")%
None 39.86666666666667.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ancora Advisors LLC holds $4,503,700 across 42 Biotechnology names. GLSI ranks #2 (20.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OMER |
Omeros Corp
|
115,000 | $1,214,400 | |
| 2 | GLSI |
Greenwich LifeSciences, Inc.
This page
|
37,500 | $900,750 | |
| 3 | CRVS |
Corvus Pharmaceuticals, Inc.
|
54,768 | $801,255 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,050 | $468,867 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
4,016 | $191,041 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
2,391 | $179,540 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
20,000 | $153,400 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
4,316 | $93,916 |
All Filings in GLSI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $900,750 | 37,500 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||